Citations

Showing 10 of 108119 citations.

Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein–Barr virus
Lu, Changli, Huang, He, Qiu, Tingting , Lu, Qiang , Huang, Chengwu , Gong, Ping , Chen, Shigao , Ling, Wenwu, Gong, Ping , Huang, Chengwu , Ling, Wenwu , Luo, Yan

Mayo Clinic

Medicine | January 17, 2019 | Volume: 98 | Issue: 3 | Pages: e14206

10.1097/md.0000000000014206 | PMID 30653176 Get It

Abstract Rationale: Epstein–Barr virus (EBV)-related lymphoepithelioma-like cholangiocarcinoma (LELCC) is an extremely rare primary liver tumor with nonspecific clinical manifestations. The clinicopathological features of EBV-associated LELCC have been reported in a few cases. But reports of the tumor's imaging characteristics, particularly ultrasonographic findings, are very rare. Patient concerns: The first patient was a 64-year-old man with left upper quadrant pain and no nausea and dizziness for about 3 months. The second patient was a 40-year-old man, had an incidental finding of a hepatic tumor in a routine health checkup at a local hospital. Diagnoses: In the first patient, the abdominal ultrasound demonstrated a slightly heterogeneous hypoechoic nodule in segment 3 of the liver. The nodule was about 2.0 cm × 1.7 cm in size, with a clear margin and regular shape. Color Doppler flow imaging (CDFI) revealed no blood flow signals in this nodule. According to the clinical information and imaging features, it was difficult to determine the diagnosis of the nodule. In the second patient, gray-scale ultrasound revealed a slightly heterogeneous hypoechoic mass measuring 3.5 cm × 2.5 cm with well-defined margin and regular shape at the superior segment of the left hepatic lateral lobe. There was a blurrily hypoechoic halo around the mass. In contrast-enhanced ultrasound (CEUS), the mass was homogeneous hyperenhancement in the arterial phase. In the portal phase and late phase, the center enhancement of the mass washed out gradually, presenting hypoenhancement, Therefore, the tumor was diagnosed as malignancy. Intervention: Finally, a laparoscopic left hepatic lateral lobectomy was performed in the first patient. The second patient underwent a left hepatectomy with cholecystectomy. Outcomes: The first patient has been alive without recurrence or distant metastases for 11 months since the surgery. The second patient received routine follow-up after surgery. Until now, he has been tumor-free for 32 months. Lessons: We mainly focus on the ultrasound characteristics of EBV-associated LELCC, especially its enhancement patterns on CEUS, which may provide valuable information for diagnosis of the LELCC. When a liver tumor with typical CEUS patterns of malignancy is found in middle-aged adults with EBV positive, the possibility of EBV-related LELCC should be considered.
Characteristics and proposed classification system of posterior pilon fractures
Zhang, Jianzheng , Pen, Cheng, Qu, Wen-chun, Duan, Lida, Ren, Jixin, Qu, Wenchun , Wang, Hao , Li, Lianhua , Liu, Zhi , Sun, Tiansheng

Mayo Clinic

Medicine | January 17, 2019 | Volume: 98 | Issue: 3 | Pages: e14133

10.1097/md.0000000000014133 | PMID 30653144 Get It

Abstract Posterior pilon fractures involve the medial malleolus (MM). Our purpose was to define the characteristics of posterior pilon fractures, and propose a classification system based on fracture morphology and type of management. The records of patients with posterior pilon fractures treated from 2011 to 2015 were retrospectively reviewed. The injury mechanism, fracture morphology, surgical approach, and follow-up results were reviewed and analyzed. This study was approved by the Institutional Review Board of PLA Army General Hospital. Thirty-six patients, 18 males and 18 females (mean age: 48.9 years) were included in the study. Four characteristics were used to define posterior pilon fractures. A simple posterolateral approach or a combined posterolateral and posteromedial approach was used for reduction and fixation in all patients. The mean follow-up time was 28.2 months, and at the end of follow-up, the mean American Orthopedic Foot and Ankle Society Score (AOFAS) was 82.5 points (range: 35–100 points). Based on injury mechanism and fracture morphology, we classified posterior pilon fractures into 3 types that suggest the optimal surgical approach: type I, a single complete fracture fragment; type II, a posterior malleolus fracture with 2 subtypes; type III, a posterior malleolus fracture associated with complete MM fracture with 2 subtypes. The proposed classification system based on injury mechanism and fracture morphology can guide the surgical approach to maximize outcomes.
Autonomic nervous system and neuroimmune interactions
Benarroch, Eduardo E.

Mayo Clinic

Neurology | January 17, 2019 | Volume: 92 | Issue: 8 | Pages: 377-385

10.1212/wnl.0000000000006942 | PMID 30651384 Get It

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator
Vella, Adrian , Freeman, Jennifer L. R., Dunn, Imogene, Keller, Kit A., Buse, John B. , Valcarce, Carmen, Vella, Adrian , Keller, Kit, Buse, John B

Mayo Clinic

Science Translational Medicine | January 17, 2019 | Volume: 11 | Issue: 475 | Pages: No page available

10.1126/scitranslmed.aau3441 | PMID 30651321 Get It

A hepatoselective glucokinase activator reduced hyperglycemia without hypoglycemia or adverse effects on lipids, liver enzymes, or blood pressure.
Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?
Lee, Lisa Eunyoung , Chan, Jillian, Nevill, Emilie, Soares, Adam, Vavasour, Irene M. , Garren, Hideki, Clayton, David , Tam, Roger , Kolind, Shannon , Carruthers, Robert , MacMillan, Erin L. , Keegan, B. Mark , Traboulsee, Anthony , Kollind, Shannon H , Lee, Lisa Eunyoung , Tam, Roger

Mayo Clinic

Multiple Sclerosis Journal - Experimental, Translational and Clinical | January 16, 2019 | Volume: 5 | Issue: 1 | Pages: No page available

10.1177/2055217318824612 | PMID 30729027 Get It

Background Progressive solitary sclerosis is a unifocal demyelinating disease recently proposed as a possible multiple sclerosis variant. Objective To compare myelin content and brain metabolite ratio qualitatively in the normal-appearing white matter of progressive solitary sclerosis cases compared to multiple sclerosis and healthy control participants. Methods Case report. Results Progressive solitary sclerosis cases showed abnormal myelin in normal-appearing white matter tracts and global normal-appearing white matter as well as lower N-acetyl-aspartate to total creatine ratio compared to multiple sclerosis and healthy control groups. Conclusion Despite a single demyelinating lesion along the corticospinal tract in progressive solitary sclerosis, we showed evidence of more extensive abnormality within the normal-appearing white matter.
Postoperative epidural analgesia versus systemic analgesia for thoraco-lumbar spine surgery in children
Guay, Joanne, Suresh, Santhanam , Kopp, Sandra L. , Johnson, Rebecca L.

Mayo Clinic

Cochrane Database of Systematic Reviews | January 16, 2019 | Volume: 2019 | Issue: 1 | Pages: No page available

10.1002/14651858.cd012819.pub2 | PMID 30650189 Get It

Hippo signaling promotes lung epithelial lineage commitment by curbing Fgf10 and β-catenin signaling
Volckaert, Thomas, Yuan, Tingting , Yuan, Jie , Boateng, Eistine , Hopkins, Seantel, Zhang, Jin‐San , Fässler, Reinhard , Langhe, Stijn De , De Langhe, Stijn P , Thannickal, Victor J.

Mayo Clinic

Development | January 16, 2019 | Volume: 146 | Issue: 2 | Pages: No page available

10.1242/dev.166454 | PMID 30651296 Get It

ABSTRACTOrgan growth and tissue homeostasis rely on the proliferation and differentiation of progenitor cell populations. In the developing lung, localized Fgf10 expression maintains distal Sox9-expressing epithelial progenitors and promotes basal cell differentiation in the cartilaginous airways. Mesenchymal Fgf10 expression is induced by Wnt signaling but inhibited by Shh signaling, and epithelial Fgf10 signaling activates β-catenin signaling. The Hippo pathway is a well-conserved signaling cascade that regulates organ size and stem/progenitor cell behavior. Here, we show that Hippo signaling promotes lineage commitment of lung epithelial progenitors by curbing Fgf10 and β-catenin signaling. Our findings show that both inactivation of the Hippo pathway (nuclear Yap) or ablation of Yap result in increased β-catenin and Fgf10 signaling, suggesting a cytoplasmic role for Yap in epithelial lineage commitment. We further demonstrate redundant and non-redundant functions for the two nuclear effectors of the Hippo pathway, Yap and Taz, during lung development.
Pharmacology of bisphosphonates
Cremers, Serge , Drake, Matthew T. , Ebetino, Frank H. , Bilezikian, John P. , Russell, R.G.G. , Russell, R Graham , Drake, Matthew T

Mayo Clinic

British Journal of Clinical Pharmacology | January 16, 2019 | Volume: 85 | Issue: 6 | Pages: 1052-1062

10.1111/bcp.13867 | PMID 30650219 Get It

The biological effects of the bisphosphonates (BPs) as inhibitors of calcification and bone resorption were first described in the late 1960s. In the 50 years that have elapsed since then, the BPs have become the leading drugs for the treatment of skeletal disorders characterized by increased bone resorption, including Paget's disease of bone, bone metastases, multiple myeloma, osteoporosis and several childhood inherited disorders. The discovery and development of the BPs as a major class of drugs for the treatment of bone diseases is a paradigm for the successful journey from “bench to bedside and back again”. Several of the leading BPs achieved “blockbuster” status as branded drugs. However, these BPs have now come to the end of their patent life, making them highly affordable. The opportunity for new clinical applications for BPs also exists in other areas of medicine such as ageing, cardiovascular disease and radiation protection. Their use as inexpensive generic medicines is therefore likely to continue for many years to come. Fifty years of research into the pharmacology of bisphosphonates have led to a fairly good understanding about how these drugs work and how they can be used safely in patients with metabolic bone diseases. However, while we seemingly know much about these drugs, a number of key aspects related to BP distribution and action remain incompletely understood. This review summarizes the existing knowledge of the (pre)clinical and translational pharmacology of BPs, and highlights areas in which understanding is lacking.
The gender affirmative lifespan approach (GALA): A framework for competent clinical care with nonbinary clients
Rider, G. Nic , Vencill, Jennifer A. , Berg, Dianne , Becker-Warner, Rachel, Candelario-Pérez, Leonardo, Spencer, Katherine G., Rider, G. Nic

Mayo Clinic

International Journal of Transgenderism | January 16, 2019 | Volume: 20 | Issue: 2-3 | Pages: 275-288

10.1080/15532739.2018.1485069 | PMID 32999613 Get It

Previous coronary artery bypass graft is not associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis
Prasitlumkum, Narut , Kanitsoraphan, Chanavuth , Rattanawong, Pattara , Mekritthikrai, Raktham , Gillaspie, Erin A. , Mao, Michael A. , Cheungpasitporn, Wisit , Rattanawong, Pattara , Mao, Michael A , Cheungpasitporn, Wisit , Kanitsoraphan, Chanavuth , Prasitlumkum, Narut , Kewcharoen, Jakrin

Mayo Clinic

Acta Cardiologica | January 16, 2019 | Volume: 75 | Issue: 1 | Pages: 26-34

10.1080/00015385.2018.1541845 | PMID 30650054 Get It